204 related articles for article (PubMed ID: 8245337)
21. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons.
Müller G; Deal BJ; Strasburger JF; Benson DW
Am J Cardiol; 1993 Mar; 71(7):592-5. PubMed ID: 8438747
[TBL] [Abstract][Full Text] [Related]
22. Role of endogenous opioids in syncope induced by head-up tilt test and its relationship with isoproterenol-dependent and isoproterenol-independent neurally-mediated syncope.
Pérez-Paredes M; Picó-Aracil F; Fuentes-Jiménez T; Sánchez-Villanueva JG; Expósito-Ordoñez E; Gonzálvez-Ortega M; González-Caballero E; Nicolás-Garcia F; Nuño de la Rosa JA; Ruiz-Ros JA; Ruipérez-Abizanda JA
Int J Cardiol; 1998 Dec; 67(3):211-8. PubMed ID: 9894701
[TBL] [Abstract][Full Text] [Related]
23. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope.
Brignole M; Menozzi C; Gianfranchi L; Lolli G; Bottoni N; Oddone D
Am J Cardiol; 1992 Aug; 70(3):339-42. PubMed ID: 1632399
[TBL] [Abstract][Full Text] [Related]
24. Head-up tilt test in patients with high pretest likelihood of neurally mediated syncope: an approximation to the "real sensitivity" of this testing.
Pérez-Paredes M; Picó-Aracil F; Florenciano R; Sánchez-Villanueva JG; Ruiz Ros JA; Ruipérez JA
Pacing Clin Electrophysiol; 1999 Aug; 22(8):1173-8. PubMed ID: 10461293
[TBL] [Abstract][Full Text] [Related]
25. Significance of circulatory epinephrine levels in exercise-induced neurally mediated syncope.
Takase B; Kastushika S; Hamabe A; Uehata A; Isojima K; Satomura K; Nishioka T; Ohsuzu F; Kurita A
Clin Cardiol; 2001 Jan; 24(1):15-20. PubMed ID: 11195600
[TBL] [Abstract][Full Text] [Related]
26. Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin.
Grubb BP; Temesy-Armos P; Hahn H; Elliott L
Am J Med; 1991 Jan; 90(1):6-10. PubMed ID: 1670907
[TBL] [Abstract][Full Text] [Related]
27. Continuous monitoring of an endocardial index of myocardial contractility during head-up tilt test.
Deharo JC; Peyre JP; Chalvidan T; Thirion X; Valli M; Ritter P; Djiane P
Am Heart J; 2000 Jun; 139(6):1022-30. PubMed ID: 10827383
[TBL] [Abstract][Full Text] [Related]
28. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial.
Brignole M; Menozzi C; Moya A; Andresen D; Blanc JJ; Krahn AD; Wieling W; Beiras X; Deharo JC; Russo V; Tomaino M; Sutton R;
Circulation; 2012 May; 125(21):2566-71. PubMed ID: 22565936
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a single-stage isoproterenol-tilt table test in patients with syncope.
Sheldon R
J Am Coll Cardiol; 1993 Jul; 22(1):114-8. PubMed ID: 8509530
[TBL] [Abstract][Full Text] [Related]
30. Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease.
Chen XC; Chen MY; Remole S; Kobayashi Y; Dunnigan A; Milstein S; Benditt DG
Am J Cardiol; 1992 Mar; 69(8):755-60. PubMed ID: 1546650
[TBL] [Abstract][Full Text] [Related]
31. Left ventricular dimensions and autonomic balance during head-up tilt differ between patients with isoproterenol-dependent and isoproterenol-independent neurally mediated syncope.
Mizumaki K; Fujiki A; Tani M; Shimono M; Hayashi H; Inoue H
J Am Coll Cardiol; 1995 Jul; 26(1):164-73. PubMed ID: 7797746
[TBL] [Abstract][Full Text] [Related]
32. Characterization of subcutaneous microvascular blood flow during tilt table-induced neurally mediated syncope.
Benditt DG; Chen MY; Hansen R; Buetikofer J; Lurie K
J Am Coll Cardiol; 1995 Jan; 25(1):70-5. PubMed ID: 7798529
[TBL] [Abstract][Full Text] [Related]
33. Methodology of isoproterenol-tilt table testing in patients with syncope.
Sheldon R; Killam S
J Am Coll Cardiol; 1992 Mar; 19(4):773-9. PubMed ID: 1545073
[TBL] [Abstract][Full Text] [Related]
34. Exercise-induced neurally mediated syncope.
Abe H; Iwami Y; Nakashima Y; Kohshi K; Kuroiwa A
Jpn Heart J; 1997 Jul; 38(4):535-9. PubMed ID: 9350150
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope.
Strieper MJ; Campbell RM
J Am Coll Cardiol; 1993 Aug; 22(2):594-7. PubMed ID: 8101533
[TBL] [Abstract][Full Text] [Related]
36. Assessment of autonomic function in patients with neurally mediated syncope: augmented cardiopulmonary baroreceptor responses to graded orthostatic stress.
Sneddon JF; Counihan PJ; Bashir Y; Haywood GA; Ward DE; Camm AJ
J Am Coll Cardiol; 1993 Apr; 21(5):1193-8. PubMed ID: 8459076
[TBL] [Abstract][Full Text] [Related]
37. Different mechanisms of isoproterenol-induced and nitroglycerin-induced syncope during head-up tilt in patients with unexplained syncope: important role of epinephrine in nitroglycerin-induced syncope.
Takase B; Uehata A; Nishioka T; Isojima K; Satomura K; Ohsuzu F; Kurita A
J Cardiovasc Electrophysiol; 2001 Jul; 12(7):791-6. PubMed ID: 11469429
[TBL] [Abstract][Full Text] [Related]
38. The effect of atropine in vasovagal syncope induced by head-up tilt testing.
Santini M; Ammirati F; Colivicchi F; Gentilucci G; Guido V
Eur Heart J; 1999 Dec; 20(23):1745-51. PubMed ID: 10562483
[TBL] [Abstract][Full Text] [Related]
39. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
[TBL] [Abstract][Full Text] [Related]
40. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope.
Sra JS; Murthy VS; Jazayeri MR; Shen YH; Troup PJ; Avitall B; Akhtar M
J Am Coll Cardiol; 1992 Feb; 19(2):402-8. PubMed ID: 1346266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
